We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Growing Use of Robots in Labs

By Biotechdaily staff writers
Posted on 21 Apr 2005
The lack of highly skilled labor that has been a major issue for medical device manufacturers and clinical and pharmaceutical research laboratories has been solved by having robots substitute for human labor in these applications, according to a new analysis by Frost & Sullivan (Palo Alto, CA, USA), a global growth consulting company.

Robotic systems are increasingly being adopted in order to improve productivity and efficiency as the demand for more sophisticated medical devices and newer drugs continues to grow. More...
The new analysis revealed that the total market in North America for industrial robots for medical and pharmaceutical applications in 2004 was U.S.$384 million and is expected to reach $668 million by 2011.

Robots have great potential to enhance efficiency and throughput in clinical laboratories, where samples need to be delivered from patients' bedsides to the test equipment and then to the analyzers on a daily basis. This is due to the distinct advantage they have over human-based delivery methods in terms of quicker transportation and a much greater handling capacity.

"As technology improves, more features are likely to be added to robotics systems, not only for delivery but also for testing and analyzing the samples,” noted Kishan Bhat, a research analyst with Frost & Sullivan. "This will enhance the efficiency of the robots, and in turn, boost the throughput of the laboratories.”

However, industrial robotics manufacturers face several challenges in their efforts to establish themselves in medical and pharmaceutical applications. Key among these is the incompatibility of their controller software with existing installed equipment. In most cases, this proprietary software is not upgraded frequently to meet the changing application requirements. The introduction of open architecture controllers is expected to reduce this challenge, however.

The emergence of stand-alone workstations in pharmaceutical labs is another strong challenge. While these can handle liquids for microplates within a limited capacity, they do not need manual intervention during the process, are less expensive, and occupy less space than total automated robotics systems. Because of these advantages, many pharmaceutical labs are opting for partial automation of their facilities even though fully automated robotics systems are more flexible and accurate. An increasing number of labs are considering microfluidics as an effective way of reducing costs, because of their ability to miniaturize chemical assays and thereby increase portability.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.